10-Q: Cantor Equity Partners V files Q3, closes $250M IPO

Cantor Equity Partners V reported nominal pre-IPO Q3 results and, after quarter-end, completed a $250 million SPAC IPO with funds placed in trust to pursue a business combination by November 5, 2027.

Summary

• Early-stage SPAC with no operating revenues; Q3 2025 net loss was $42,945 and nine‑month 2025 net loss was $43,618, driven by general and administrative costs.
• As of September 30, 2025: assets $164,309 (deferred offering costs), liabilities $209,809 (accrued expenses $91,634; related-party note $118,175), and shareholders’ deficit of $45,500; working capital deficit ≈$210,000.
• Subsequent event: on November 5, 2025, completed IPO of 25,000,000 Class A shares at $10.00 per share (including 3,000,000 from partial over-allotment) for gross proceeds of $250,000,000; concurrent private placement of 540,000 Class A shares to Sponsor at $10.00 for $5,400,000.
• $250,000,000 was placed in a U.S. trust account and transferred on November 6, 2025 to CF Secured, LLC (an affiliate of the Sponsor), invested in U.S. Treasury bills or eligible money market funds.
• Offering costs totaled approximately $4,900,000, including $4,400,000 in underwriting discounts and $100,000 to a qualified independent underwriter; a $9,350,000 business combination marketing fee is payable upon a successful de‑SPAC.
• Sponsor support: up to $1,750,000 Sponsor Loan available (undrawn as of 9/30/25), convertible at $10.00 per share beginning 60 days after the IPO; $10,000 per month administrative services fee commenced November 4, 2025.
• Founder share recapitalizations and adjustments leave 6,250,000 Class B shares outstanding post‑IPO; as of December 16, 2025, there were 25,540,000 Class A and 6,250,000 Class B shares outstanding.
• Deadline: must complete a business combination by November 5, 2027 or liquidate; standard public shareholder redemption rights at approximately $10.00 per share apply.

Sentiment

Score: 6

Explanation: Neutral-to-positive: the trust is fully funded and costs are in line with SPAC norms, but there is no target yet, ongoing small losses, and increased regulatory/process complexity ahead.

Positives

• Post‑quarter IPO closed with $250,000,000 deposited into the trust account, providing full funding for a target search.
• Additional $5,400,000 raised via private placement to the Sponsor, bolstering resources.
• Sponsor committed up to $1,750,000 of additional, convertible working capital financing at $10.00 per share, with no interest.
• Standard SPAC protections: public shareholders may redeem at approximately $10.00 per share; Sponsor agreed to protect trust funds from certain vendor claims down to $10.00 per share.
• Disclosure controls and procedures were deemed effective as of September 30, 2025.

Negatives

• No operating revenues and continued losses (Q3 2025 net loss $42,945; nine‑month 2025 net loss $43,618).
• Meaningful transaction-related fees (approximately $4,900,000 offering costs and a $9,350,000 business combination marketing fee) reduce cash ultimately available for a de‑SPAC.
• Trust funds were transferred to an affiliate (CF Secured), introducing related‑party optics and governance scrutiny.
• Pre‑IPO working capital deficit of approximately $210,000 and reliance on Sponsor financing for ongoing expenses.

Risks

• Must complete a business combination by November 5, 2027 or redeem the public shares and liquidate.
• Macroeconomic and market factors (financial market downturns, interest rate fluctuations, geopolitical instability) could impair target availability, valuation, or timing.
• New SEC SPAC Rules (effective July 1, 2024) increase disclosure, liability, and process complexity and may lengthen timelines and raise costs.
• Potential Investment Company Act considerations noted by the SEC’s guidance for SPACs could affect structure or operations if implicated.

Future Outlook

Management plans to identify and consummate a business combination by November 5, 2027, fund near-term costs with existing resources and, if needed, the undrawn $1.75 million Sponsor Loan, while investing trust assets in short-duration U.S. government securities; regulatory changes to SPAC disclosures and market conditions may affect timing and costs.

Management Comments

• Believes sufficient working capital and borrowing capacity from the Sponsor exist to meet needs through the earlier of a business combination or one year from the report date.
• Expects to use funds for due diligence, travel, legal and advisory costs, and negotiation/consummation of a business combination.
• Acknowledges that new SEC SPAC rules and macro/geopolitical factors could increase costs, extend timelines, or affect target availability.
• Concluded disclosure controls and procedures were effective as of September 30, 2025.

Industry Context

The SPAC’s terms are broadly standard: $10.00 per-share trust, 24‑month combination window, and a fee structure that includes an upfront underwriting discount and a deferred marketing fee; however, the SEC’s 2024 SPAC Rules increase disclosure and process requirements across the sector, potentially elongating deal timelines and raising costs for Cantor Equity Partners V and peers seeking targets in financial services, digital assets, healthcare, real estate services, technology, and software.

Comparison to Industry Standards

• Funding and timeline: $250 million trust funded at $10.00 per share with a 24‑month deadline (to November 5, 2027) align with common SPAC market norms.
• Fee load: The $4.4 million upfront underwriting discount (1.76% of IPO proceeds) plus the $9.35 million business combination marketing fee (3.74%) total 5.50% of gross proceeds—essentially in line with typical SPAC economics (~5.5% combined).
• Security structure: Shares-only IPO without disclosed warrants is less dilutive than many SPAC peers that issue units with warrants, potentially improving pro forma capital structure at de‑SPAC.
• Sponsor financing: The undrawn, non‑interest‑bearing $1.75 million Sponsor Loan convertible at $10.00 per share is consistent with common SPAC working capital facilities, providing flexibility without immediate cash interest burden.

Related Party Transactions

• CF&Co., an affiliate of the Sponsor, served as lead underwriter; received a $4,400,000 underwriting discount and is entitled to a $9,350,000 business combination marketing fee upon de‑SPAC.
• CF Secured, LLC (an affiliate of the Sponsor) holds the $250,000,000 trust account funds transferred on November 6, 2025.
• Sponsor provided a pre‑IPO promissory note (up to $300,000; $118,175 drawn as of 9/30/25; repaid at IPO close).
• Sponsor committed up to $1,750,000 in a non‑interest‑bearing, convertible Sponsor Loan, undrawn as of 9/30/25.
• Administrative services agreement with the Sponsor for $10,000 per month starting November 4, 2025.
• Sponsor purchased 540,000 Class A shares in a private placement at $10.00 per share concurrent with the IPO.

Stakeholder Impact

• Public shareholders benefit from redemption rights at approximately $10.00 per share and a fully funded trust, but net cash available at de‑SPAC will be reduced by transaction fees and any redemptions.
• Sponsor and insiders waived redemption rights for founder and private placement shares, aligning with completion of a business combination but concentrating voting influence pre‑deal.
• Creditors and vendors are expected to sign trust waivers; the Sponsor agreed to protect trust funds from certain vendor claims down to $10.00 per share.
• Potential dilution for shareholders could arise from conversion of the $1.75 million Sponsor Loan at $10.00 per share and the conversion of founder shares at de‑SPAC.

Next Steps

• Identify, evaluate, and negotiate a business combination target within the November 5, 2027 deadline.
• Fund search and diligence costs from available cash outside the trust and, if needed, draw on the $1.75 million Sponsor Loan.
• Maintain trust investments in short-duration U.S. government securities or eligible money market funds.
• Comply with enhanced SPAC disclosure requirements and prepare for shareholder vote or tender process upon signing a definitive agreement.

Key Dates

Recommendation

The vehicle is fully funded post‑quarter with standard SPAC terms and timelines, but no target has been announced and transaction costs will reduce eventual cash delivered. A hold stance is appropriate pending visibility on a definitive business combination and redemption dynamics.

Keywords

SPAC, initial public offering, trust account, business combination, Cantor Fitzgerald, Private Placement, Class A ordinary shares, Founder Shares, CF Secured, Sponsor Loan, Nasdaq, Cayman Islands